ACSL3 and urinary bladder carcinoma: METTL7B expression promotes m6A modification on Acyl-CoA Synthetase Long Chain Family Member 3 (ACSL3) mRNA, thereby reducing ACSL3 gene expression and ultimately inhibiting ferroptosis in bladder cancer [101].